New Hope Clinical Research

New Hope Clinical Research is a privately-held clinical trial site management organization with a nearly 20-year operational history in Charlotte, NC. It provides clinical trial execution services for pharmaceutical and biotechnology sponsors, operating a Phase I-IV unit that has successfully passed an FDA audit with no deficiencies. The company focuses on central nervous system disorders and oncology, leveraging its experienced team and facility to participate in mid-to-late-stage clinical studies, as evidenced by its ongoing involvement in depression and historical Alzheimer's trials.

Operational clinical trial site infrastructure, including a Phase I-IV capable facility with a quality management system validated by a successful FDA audit with no findings. Utilizes standard clinical trial technologies for data capture, management, and regulatory compliance.

Competes within the fragmented clinical trial site sector, facing competition from other independent sites, large site networks (SMOs), and academic medical centers. Differentiation is based on therapeutic expertise, patient recruitment speed, data quality, regulatory track record, and geographic location.